We are live on ! Find out more
BACM

Blue Arrow Capital Management Portfolio holdings

AUM $369M
1-Year Est. Return 18.08%
This Fund
S&P 500
This Quarter Est. Return
+9.25%
1 Year Est. Return
+18.08%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$887M
AUM Growth
-$36.3M
Cap. Flow
-$49.8M
Cap. Flow %
-5.61%
Top 10 Hldgs %
31.43%
Holding
279
New
99
Increased
39
Reduced
42
Closed
94

Top Buys

Rank Stock Value
1
LVLT
Level 3 Communications Inc
LVLT
+$19M
2
MHK icon
Mohawk Industries
MHK
+$18.6M
3
SBH icon
Sally Beauty Holdings
SBH
+$17.9M
4
GRPN icon
Groupon
GRPN
+$17M
5
MCD icon
McDonald's
MCD
+$13.1M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$19.3M
2
AAP icon
Advance Auto Parts
AAP
+$17.6M
3
PVH icon
PVH
PVH
+$14.9M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$12.5M
5
TCOM icon
Trip.com Group
TCOM
+$12.4M

Sector Composition

Rank Sector Weight
1 Communication Services 27.67%
2 Consumer Discretionary 22.85%
3 Financials 16.98%
4 Miscellaneous 11.1%
5 Industrials 6.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GRPN icon
126
CALL
Groupon
GRPN
$794M
$1.32M 0.15%
+8,000
New +$1.14M
RGA icon
127
Reinsurance Group of America
RGA
$16B
$1.31M 0.15%
+15,000
New +$1.25M
JNS
128
DELISTED
Janus Capital Group Inc
JNS
$1.31M 0.15%
+81,368
New +$1.22M
STJ
129
CALL
DELISTED
St Jude Medical
STJ
$1.3M 0.15%
+20,000
New +$1.29M
TWC
130
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
$1.26M 0.14%
+8,294
New +$1.2M
AMP icon
131
Ameriprise Financial
AMP
$49.4B
$1.26M 0.14%
+9,501
New +$1.2M
IRWD icon
132
Ironwood Pharmaceuticals
IRWD
$682M
$1.21M 0.14%
94,641
-1,345
-1% -$15.4K
VRTX icon
133
PUT
Vertex Pharmaceuticals
VRTX
$137B
$1.19M 0.13%
10,000
-10,000
-50% -$1.13M
QDEL icon
134
QuidelOrtho
QDEL
$1.01B
$1.16M 0.13%
+40,000
New +$1.08M
STL
135
DELISTED
Sterling Bancorp
STL
$1.15M 0.13%
+80,000
New +$1.08M
ABMD
136
DELISTED
Abiomed Inc
ABMD
$1.14M 0.13%
+30,000
New +$946K
ABG icon
137
Asbury Automotive
ABG
$3.8B
$1.14M 0.13%
+15,000
New +$1.08M
ZBH icon
138
CALL
Zimmer Biomet
ZBH
$19.2B
$1.13M 0.13%
+10,300
New +$1.09M
REGN icon
139
Regeneron Pharmaceuticals
REGN
$81.8B
$1.13M 0.13%
+2,754
New +$1.08M
TCF
140
DELISTED
TCF Financial Corporation
TCF
$1.11M 0.13%
+70,000
New +$1.08M
AF
141
DELISTED
Astoria Financial Corporation
AF
$1.11M 0.13%
83,082
– –
DFS
142
DELISTED
Discover Financial Services
DFS
$1.08M 0.12%
+16,565
New +$1.06M
RIGL icon
143
Rigel Pharmaceuticals
RIGL
$868M
$1.02M 0.12%
45,000
-20,000
-31% -$405K
WBS
144
DELISTED
Webster Financial
WBS
$1.02M 0.12%
31,432
-13,568
-30% -$420K
SEIC icon
145
SEI Investments
SEIC
$13.4B
$1M 0.11%
25,000
-25,000
-50% -$958K
CATY icon
146
Cathay General Bancorp
CATY
$4.13B
$956K 0.11%
+37,366
New +$948K
CCXI
147
DELISTED
ChemoCentryx, Inc.
CCXI
$956K 0.11%
+140,000
New +$740K
PFE icon
148
CALL
Pfizer
PFE
$159B
$935K 0.11%
+31,620
New +$907K
MNTA
149
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$843K 0.1%
70,000
+50,000
+250% +$571K
WMGI
150
DELISTED
Wright Medical Group Inc
WMGI
$806K 0.09%
30,000
-40,000
-57% -$1.17M
4 5
6
7 8

Similar funds

CWA
Convergent Wealth Advisors Potomac, Maryland $442M AUM 7.38% 1-Year Est. Return
TCOTO
Trust Company of the Ozarks Springfield, Missouri $290M AUM 12.7% 1-Year Est. Return
DCM
Decade Capital Management New York $463M AUM 13.44% 1-Year Est. Return
CCM
Catapult Capital Management New York $265M AUM 21.83% 1-Year Est. Return
LOCB
Lombard Odier & Cie (Bahamas) Nassau, Bahamas $263M AUM 3.37% 1-Year Est. Return
AF
Adirondack Funds Guilderland, New York $261M AUM
DCM
Dinsmore Capital Management Morristown, New Jersey $230M AUM 0.29% 1-Year Est. Return
SCA
Samson Capital Advisors New York $228M AUM 0.84% 1-Year Est. Return

Blue Arrow Capital Management's Q4 2014 Portfolio in Review

As of Q4 2014, Blue Arrow Capital Management held 279 positions worth $887M, down 3.9% from $923M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Blue Arrow Capital Management withdrew a net $49.8M in Q4 2014, closing 94 positions and reducing 42 holdings. Its most notable exit was Apple, an estimated $19.3M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 28% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Blue Arrow Capital Management opened a new position in Mohawk Industries worth $20.1M.

  • Blue Arrow Capital Management's largest Q4 2014 buy was Mohawk Industries: 129,339 shares worth $20.1M.
  • Blue Arrow Capital Management added most to Level 3 Communications Inc in Q4 2014, an estimated $19M increase.
  • Blue Arrow Capital Management's biggest Q4 2014 reduction was Advance Auto Parts, cutting an estimated $17.6M.
  • Blue Arrow Capital Management fully exited Apple in Q4 2014, selling an estimated $19.3M.
  • Blue Arrow Capital Management's ten largest holdings make up 31% of its $887M portfolio in Q4 2014.
  • Blue Arrow Capital Management opened 99 new positions and closed 94 in Q4 2014.
  • Blue Arrow Capital Management's portfolio value fell 3.9% quarter-over-quarter to $887M.

Based on Blue Arrow Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.